150 related articles for article (PubMed ID: 38418448)
21. Differences in survival among multiple myeloma patients in the United States SEER population by neighborhood socioeconomic status and race/ethnicity.
Castañeda-Avila MA; Jesdale BM; Beccia A; Bey GS; Epstein MM
Cancer Causes Control; 2021 Sep; 32(9):1021-1028. PubMed ID: 34089470
[TBL] [Abstract][Full Text] [Related]
22. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
[TBL] [Abstract][Full Text] [Related]
23. Socioeconomic status-based survival disparities and nomogram prediction for patients with multiple myeloma: Results from American and Chinese populations.
Xu J; Xu P; Han Q; Sun J; Chen B; Dong X
Front Oncol; 2022; 12():941714. PubMed ID: 36091116
[TBL] [Abstract][Full Text] [Related]
24. Socioeconomic status and severity-based incidence of poisoning: a nationwide cohort study.
Song KJ; Shin SD; Cone DC
Clin Toxicol (Phila); 2009 Sep; 47(8):818-26. PubMed ID: 19640232
[TBL] [Abstract][Full Text] [Related]
25. Identifying predictive factors for vertebral collapse fractures in multiple myeloma patients.
Zijlstra H; Wolterbeek N; Drost RW; Koene HR; van der Woude HJ; Terpstra WE; Delawi D; Kempen DHR
Spine J; 2020 Nov; 20(11):1832-1839. PubMed ID: 32673729
[TBL] [Abstract][Full Text] [Related]
26. Geriatric assessment in multiple myeloma patients: validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores.
Engelhardt M; Dold SM; Ihorst G; Zober A; Möller M; Reinhardt H; Hieke S; Schumacher M; Wäsch R
Haematologica; 2016 Sep; 101(9):1110-9. PubMed ID: 27479825
[TBL] [Abstract][Full Text] [Related]
27. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Hong S; Rybicki L; Abounader D; Bolwell BJ; Dean R; Gerds AT; Hamilton BK; Hill BT; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1141-1144. PubMed ID: 26995694
[TBL] [Abstract][Full Text] [Related]
28. Socioeconomic Status and Dementia Risk Among Intensive Care Unit Survivors: Using National Health Insurance Cohort in Korea.
Park YS; Joo HJ; Jang YS; Jeon H; Park EC; Shin J
J Alzheimers Dis; 2024; 97(1):273-281. PubMed ID: 38143351
[TBL] [Abstract][Full Text] [Related]
29. Development of a "Myeloma Risk Score" using a population-based registry on paraproteinemia and myeloma.
Ong F; Hermans J; Noordijk EM; De Kieviet W; Seelen PJ; Wijermans PW; Kluin-Nelemans JC
Leuk Lymphoma; 1997 Nov; 27(5-6):495-501. PubMed ID: 9477131
[TBL] [Abstract][Full Text] [Related]
30. Community-level socioeconomic inequality in the incidence of ischemic heart disease: a nationwide cohort study.
Gwon JG; Choi J; Han YJ
BMC Cardiovasc Disord; 2020 Feb; 20(1):87. PubMed ID: 32087693
[TBL] [Abstract][Full Text] [Related]
31. Does neighborhood socioeconomic status predict the risk of preterm birth? A community-based Canadian cohort study.
Adhikari K; Patten SB; Williamson T; Patel AB; Premji S; Tough S; Letourneau N; Giesbrecht G; Metcalfe A
BMJ Open; 2019 Feb; 9(2):e025341. PubMed ID: 30787092
[TBL] [Abstract][Full Text] [Related]
32. Injury severity and increased socioeconomic differences: A population-based cohort study.
Madsen C; Gabbe BJ; Holvik K; Alver K; Grøholt EK; Lund J; Lyons J; Lyons RA; Ohm E
Injury; 2022 Jun; 53(6):1904-1910. PubMed ID: 35365351
[TBL] [Abstract][Full Text] [Related]
33. Dynamic frailty risk assessment among older adults with multiple myeloma: A population-based cohort study.
Mian H; Wildes TM; Vij R; Pianko MJ; Major A; Fiala MA
Blood Cancer J; 2023 May; 13(1):76. PubMed ID: 37164972
[TBL] [Abstract][Full Text] [Related]
34. Effects of individual and neighborhood socioeconomic status on the risk of all-cause mortality in chronic obstructive pulmonary disease: A nationwide population-based cohort study, 2002-2013.
Cho KH; Nam CM; Lee EJ; Choi Y; Yoo KB; Lee SH; Park EC
Respir Med; 2016 May; 114():9-17. PubMed ID: 27109806
[TBL] [Abstract][Full Text] [Related]
35. Trends in myeloma relative survival in Queensland by treatment era, age, place of residence, and socioeconomic status.
Harwood M; Dunn N; Moore J; Mollee P; Hapgood G
Leuk Lymphoma; 2020 Mar; 61(3):721-727. PubMed ID: 31724464
[TBL] [Abstract][Full Text] [Related]
36. Socioeconomic status and survival outcomes in elderly cancer patients: A national health insurance service-elderly sample cohort study.
Jang BS; Chang JH
Cancer Med; 2019 Jul; 8(7):3604-3613. PubMed ID: 31066516
[TBL] [Abstract][Full Text] [Related]
37. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population-based study.
Gregersen H; Vangsted AJ; Abildgaard N; Andersen NF; Pedersen RS; Frølund UC; Helleberg C; Broch B; Pedersen PT; Gimsing P; Klausen TW
Cancer Med; 2017 Jul; 6(7):1807-1816. PubMed ID: 28639741
[TBL] [Abstract][Full Text] [Related]
38. Clinical prediction tools to identify patients at highest risk of myeloma in primary care: a retrospective open cohort study.
Koshiaris C; Van den Bruel A; Nicholson BD; Lay-Flurrie S; Hobbs FR; Oke JL
Br J Gen Pract; 2021 May; 71(706):e347-e355. PubMed ID: 33824161
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study.
Sørrig R; Klausen TW; Salomo M; Vangsted A; Gimsing P
Eur J Haematol; 2019 Feb; 102(2):182-190. PubMed ID: 30485563
[TBL] [Abstract][Full Text] [Related]
40. Quantifying the risk of multiple myeloma from symptoms reported in primary care patients: a large case-control study using electronic records.
Shephard EA; Neal RD; Rose P; Walter FM; Litt EJ; Hamilton WT
Br J Gen Pract; 2015 Feb; 65(631):e106-13. PubMed ID: 25624306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
